Combination of Oral Rigosertib and Azacitidine in Patients with MDS

preview_player
Показать описание
At ASH 2015, Dr. Shyamala Navada from the Mount Sinai Hospital discusses her abstract titled "A Phase II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with Myelodysplastic Syndromes (MDS)."
  1. Oncology.TV
  2. ASH 2015
  3. Dr. Shyamala Navada
  4. Phase II
  5. Study
  6. Oral Rigosertib
Рекомендации по теме
Combination of Oral 0:03:58

Combination of Oral Rigosertib and Azacitidine in Patients with MDS

Phase I/II Study: 0:04:57

Phase I/II Study: Combination Rigosertib and Azacitidine in Patients with MDS or AML

Rigosertib in combination 0:01:41

Rigosertib in combination with azacitidine: a potential treatment for AML?

Oral Azacitidine and 0:06:49

Oral Azacitidine and Lenalidomide Combinations in Myelodysplastic Syndromes

Combo proves most 0:01:42

Combo proves most effective in HMA-naive, higher-risk MDS

What is the 0:00:43

What is the future for AML patients who cannot be treated with current therapy?

GC14358 Rigosertib (ON-01910,Estybon) 0:00:21

GC14358 Rigosertib (ON-01910,Estybon) 1225497-78-8

The azacitidine plus 0:03:39

The azacitidine plus romidepsin clinical trial in lymphoid malignancies

Shyamala Navada, MD, 0:00:55

Shyamala Navada, MD, MSCR, on how oral therapies will impact the treatment of myeloid malignancies

GC12415 Rigosertib 592542-59-1 0:00:26

GC12415 Rigosertib 592542-59-1

GC13580 Rigosertib sodium 0:00:26

GC13580 Rigosertib sodium 592542-60-4

Azacitidine/HDAC inhibitor combination 0:01:40

Azacitidine/HDAC inhibitor combination for high risk AML: a promising pilot study

Phase III Study 0:04:24

Phase III Study of Intravenous Rigosertib Versus Best Supportive Care (High-Risk MDS)

New nivolumab combination 0:04:20

New nivolumab combination therapies for AML

Trial of Pomalidomide, 0:05:32

Trial of Pomalidomide, Dexamethasone & Pegylated Liposomal Doxorubicin for Relapsed/Refractory M...

Novel drug targets 0:01:32

Novel drug targets for MDS

Azacitidine plus R-CHOP 0:02:18

Azacitidine plus R-CHOP Clinical Trial for Lymphoma | Weill Cornell | Lymphoma Program

Nivolumab in combination 0:01:42

Nivolumab in combination with azacitidine in patients with relapsed acute myeloid leukemia (AML)

Understanding Efficacy of 0:19:18

Understanding Efficacy of Azacitidine in Different MDS Subgroups

Onconova Therapeutics (ONTX) 0:39:14

Onconova Therapeutics (ONTX) - Channelchek Takeaway Series - The J.P.Morgan Healthcare Conference

Bone Marrow Blast 0:07:26

Bone Marrow Blast Response to Overall Survival:Higher-Risk MDS: Rigosertib After Failure of HMAs

ASH 2019 Preview: 0:39:42

ASH 2019 Preview: Potentially practice-changing studies

Dr. DiNardo on 0:00:41

Dr. DiNardo on the FDA Approval of Oral Azacitidine in AML

Understanding Efficacy of 0:25:16

Understanding Efficacy of Azacitidine in Different MDS Subgroups